Evidio Domingo Musibay, MD

NPI 1831321785ActiveIndividual· Internal Medicine, Medical Oncology· Minneapolis, MN

Internal Medicine, Medical Oncology (MD) in Minneapolis, Minnesota, trained at University of Minnesota Medical School (class of 2009). Their prescriptions cost Medicare Part D more than their services did: $383,857 for 172 claims, against $8,417 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 2 companies reporting payments in 2025, $69.25 in all, mostly education.

Overview

NPI	1831321785
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Aug 11, 2009
Last updated in NPPES	Aug 25, 2026
Certified by provider	Aug 25, 2026

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Medical Oncology Primary	207RX0202X	52977	MN
Internal Medicine, Hematology	207RH0000X	52977	MN

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026	No match	—
New York OMIG · Nov 4, 2026	No match	—
Ohio Medicaid · Nov 4, 2026	No match	—
Pennsylvania Medicheck · Nov 4, 2026	No match	—
Washington HCA · Nov 4, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Medical Oncology (MN)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	52
Services billed	93 across 12 procedure codes
Paid by Medicare	$8,417

Part D prescriptions in 2024

Prescriptions (claims)	172 · 207 30-day fills
Patients	47
Total drug cost	$383,857
Generic share	76% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Minnesota Medical School
Graduation year	2009
Medicare specialty	Medical Oncology
Secondary specialties	Hematology
Telehealth	Offers telehealth